RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors.
about
Molecular Targeted Therapies of Aggressive Thyroid CancerNext-generation sequencing in thyroid cancerSporadic medullary thyroid carcinoma: clinical data from a university hospitalMultiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an updateMedullary thyroid cancer: monitoring and therapy.Molecular diagnostics of fine needle aspiration for the presurgical screening of thyroid nodules.Is new American Thyroid Association risk classification for hereditary medullary thyroid carcinoma applicable to Chinese patients? A single-center studyAurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT.RET mutations in a large indian family with medullary thyroid carcinoma.A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo.Molecular approaches to thyroid cancer diagnosis.Development of c-MET pathway inhibitors.Determination of RET Sequence Variation in an MEN2 Unaffected Cohort Using Multiple-Sample Pooling and Next-Generation SequencingAn introduction to managing medullary thyroid cancerDasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line.Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinomaSignaling mechanisms in neuroendocrine tumors as targets for therapy.Induction of RET dependent and independent pro-inflammatory programs in human peripheral blood mononuclear cells from Hirschsprung patients.Kinome sequencing reveals RET G691S polymorphism in human neuroendocrine lung cancer cell lines.Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism.Evaluation and management of the pediatric thyroid noduleMedullary thyroid carcinoma: molecular signaling pathways and emerging therapiesNew therapies for dedifferentiated papillary thyroid cancerIdentification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase.Surgical approach to medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2.Resistance of papillary thyroid cancer stem cells to chemotherapy.A differential diagnosis of inherited endocrine tumors and their tumor counterpartsCorrelation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas.Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells.Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer.Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and diseaseXL184 (cabozantinib) for medullary thyroid carcinoma.How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid CancerCytologic and molecular diagnosis of thyroid cancers: is it time for routine reflex testing?RET TKI: potential role in thyroid cancers.Ewing sarcoma of the thyroid: report of 2 cases and review of the literature.Sorafenib and thyroid cancer.Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations.Medullary thyroid cancer diagnosis: an appraisal.Central role of RET in thyroid cancer.
P2860
Q26774734-E6CF8DF9-4968-4737-AA4D-24F4399AC3DBQ28079384-2E9FB2BE-1B13-4662-B2C1-F4A0009BF802Q33458398-529C4C17-54F6-48A3-8973-BB270F14C546Q33587821-40E9EFFB-56FB-4D69-A605-C67A44B52766Q33591999-EFBA6704-4FB3-4E86-87D4-246E4D07A78CQ33782114-BB2E7333-F913-427F-8BD8-FEFE2427DC4CQ33871900-EA639AC7-9E32-4984-BE79-485D0F5E0742Q34029020-A2179C66-F0DF-49FA-B432-50C534A139CEQ34069272-42677F99-B01C-40B3-9C56-F4D2783CA49AQ34153520-9EB7CCE2-B127-4BDC-A1C4-74939A733EF5Q34160828-E4F8061B-6F19-40E1-ABA2-4A5F7D5330C1Q34198905-44055E0D-DB63-4F62-B30E-ACD8679AE6E7Q34251415-F27C050B-467A-4755-98C3-74E292FA82FFQ34254131-FC6435A0-CE9E-44C3-AFDD-80CA366596B9Q34258443-A43F08E4-A0D3-4758-BC28-328898856EB8Q34282488-E92D37F2-C413-4128-BD0E-A29230E6C471Q34447484-BD8F2B7F-975E-446B-B45F-30B78F339F43Q34634596-8EA1F81E-8E9D-4FE7-ADA6-1F101F22E16DQ34729370-2F6E58AF-AF5D-46C6-B799-E650D3B5A964Q34948215-2636E8FC-4A18-4E94-94BB-25DBA10DC4D9Q34959924-228C3152-3B55-4CB1-A753-6FA66B59D756Q35038893-16F78F7F-96E8-4BB2-AA87-340EB158250FQ35381593-15481260-8121-4B98-BFB4-7E03A02DD01BQ35653681-795309B4-5510-477C-96CC-B291AC955081Q35895469-1DF1D389-E770-4C04-BA8C-E69517D3DA63Q37002770-62D9D6E4-9770-4FBD-8075-D1C67F455459Q37023603-6A773EDF-A459-4751-B2F8-B2943FBE5D19Q37225747-C5D32E0A-543E-415C-9B16-9B7543454032Q37236899-C8DAB407-4736-49F3-BB13-5C7AFB853352Q37275937-B9E7CCDA-3D58-4220-AE1A-F51AA9006F61Q37317139-839AD8F9-ADFF-40D6-8499-40D689B93B9CQ37840101-B50B55E8-FA1A-4255-A5E6-4193ACF91B09Q37902072-4C7CA767-29A3-4B61-B312-B502F9DE5D27Q37924711-70A12CBC-0420-4F72-B4ED-57CAC7138A7CQ37979656-FBB8458F-FBC6-4522-8712-0F8F65C4185BQ38090998-B3C7E474-CE31-4CB8-8A1A-F7A0288B388AQ38118647-0A63E176-0567-4834-BE17-163A40C0ECDCQ38124903-63B184F1-C21F-46E3-9F1F-063001C6805CQ38129820-BC03929D-19A8-4C5E-8EAF-053C680B038BQ38167995-6B00D9CB-91FE-48DB-8ECD-70AD104C9927
P2860
RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors.
@ast
RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors.
@en
type
label
RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors.
@ast
RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors.
@en
prefLabel
RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors.
@ast
RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors.
@en
P2093
P356
P1433
P1476
RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors.
@en
P2093
Cornelis J M Lips
Jan Willem B de Groot
John T M Plukker
Thera P Links
P304
P356
10.1210/ER.2006-0017
P577
2006-07-18T00:00:00Z